The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Transmedics Group Inc shares valued at $693,780 were sold by Basile Edward M on May 09 ’25. At $115.63 per share, Basile Edward M sold 6,000 shares. The insider’s holdings dropped to 732 shares worth approximately $90284.88 following the completion of this transaction.
Also, EDWARD BASILE purchased 6,000 shares, netting a total of over 693,780 in proceeds.
Before that, Khayal Tamer I had sold 2,407 shares from its account. In a trade valued at $183,967, the Chief Commercial Officer traded Transmedics Group Inc shares for $76.43 each. Upon closing the transaction, the insider’s holdings decreased to 2,407 shares, worth approximately $4.45 million.
As published in a research note from JP Morgan on December 17, 2024, Transmedics Group Inc [TMDX] has been rated down from an Overweight to a Neutral and the price target has been revised to $75 from $116. Analysts at Needham downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in late November. As of October 29, 2024, Oppenheimer has reiterated its “an Outperform” rating for TMDX. Earlier on October 29, 2024, Needham resumed its rating. Their recommendation was “a Buy” for TMDX stock.
Analyzing TMDX Stock Performance
During the last five days, there has been a surge of approximately 1.26%. Over the course of the year, Transmedics Group Inc shares have jumped approximately 97.82%. Shares of the company reached a 52-week high of $125.00 on 05/21/25 and a 52-week low of $55.00 on 01/21/25.
Support And Resistance Levels for Transmedics Group Inc (TMDX)
According to the 24-hour chart, there is a support level at 120.04, which, if violated, would cause prices to drop to 116.75. In the upper region, resistance lies at 125.39. The next price resistance is at 127.44. RSI (Relative Strength Index) is 76.98 on the 14-day chart, showing overbought technical sentiment.
